Exosome as the Prognostic and Predictive Biomarker in EBC Patients
This study is the experimental study for serial ctDNA and exosome evaluation in EBC patients
Triple Negative Breast Cancer|HER2-positive Breast Cancer
PROCEDURE: exosome and ctDNA evaluation
Prognostic biomarker for EBC, Positive predictive value of ctDNA/Exosome for BC recurrence, 60 months
This study is the experimental study for serial ctDNA and exosome evaluation in EBC patients